NasdaqCM - Delayed Quote USD
Plus Therapeutics, Inc. (PSTV)
At close: 4:00 PM EDT
After hours: 5:21 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.56 | -0.49 | -2.23 | -2.06 |
| Low Estimate | -0.78 | -0.56 | -2.43 | -3.56 |
| High Estimate | -0.35 | -0.35 | -2 | -1.35 |
| Year Ago EPS | -1 | -0.84 | -4.24 | -2.23 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | 1.52M | 1.65M | 5.35M | 5M |
| Low Estimate | 1.2M | 1.2M | 2.96M | 3.6M |
| High Estimate | 1.75M | 2M | 6.6M | 6.4M |
| Year Ago Sales | 1.24M | 1.31M | 4.91M | 5.35M |
| Sales Growth (year/est) | 22.60% | 25.70% | 8.90% | -6.50% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.12 | -1.07 | -1.09 | -0.53 |
| EPS Actual | -1 | -0.84 | -0.75 | -0.56 |
| Difference | 0.12 | 0.23 | 0.34 | -0.03 |
| Surprise % | 10.70% | 21.50% | 31.20% | -5.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.56 | -0.49 | -2.23 | -2.06 |
| 7 Days Ago | -0.56 | -0.49 | -2.23 | -2.06 |
| 30 Days Ago | -0.56 | -0.49 | -2.23 | -2.06 |
| 60 Days Ago | -0.63 | -0.53 | -2.3 | -2.29 |
| 90 Days Ago | -0.5 | -0.43 | -2.08 | -2.3 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PSTV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 44.00% | -- | -- | 3.10% |
| Next Qtr. | 41.70% | -- | -- | 8.00% |
| Current Year | 47.40% | -- | -- | 2.30% |
| Next Year | 7.60% | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 11.85% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 6/30/2023 |
| Maintains | Maxim Group: Buy | 5/3/2023 |
Related Tickers
ALRN Aileron Therapeutics, Inc.
3.6700
+2.80%
PHIO Phio Pharmaceuticals Corp.
3.1300
+0.32%
ATHE Alterity Therapeutics Limited
1.2000
-2.44%
CNTX Context Therapeutics Inc.
2.0000
-2.91%
ARTL Artelo Biosciences, Inc.
1.2200
-2.40%
NBY NovaBay Pharmaceuticals, Inc.
0.5910
-4.85%
PALI Palisade Bio, Inc.
3.7000
-5.37%
NRBO NeuroBo Pharmaceuticals, Inc.
2.8800
-0.69%
UBX Unity Biotechnology, Inc.
1.4000
0.00%
RLMD Relmada Therapeutics, Inc.
3.6400
+0.28%